These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 315462)

  • 1. The actions of tubocurarine at the frog neuromuscular junction.
    Colquhoun D; Dreyer F; Sheridan RE
    J Physiol; 1979 Aug; 293():247-84. PubMed ID: 315462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. End-plate channel opening and the kinetics of quinacrine (mepacrine) block.
    Adams PR; Feltz A
    J Physiol; 1980 Sep; 306():283-306. PubMed ID: 6257897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The modes of action of gallamine.
    Colquhoun D; Sheridan RE
    Proc R Soc Lond B Biol Sci; 1981 Mar; 211(1183):181-203. PubMed ID: 6111796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Voltage jump analysis of procaine action at frog end-plate.
    Adams PR
    J Physiol; 1977 Jun; 268(2):291-318. PubMed ID: 301570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive block and ion channel block as mechanisms of antagonist action on the skeletal muscle end-plate.
    Colquhoun D
    Adv Biochem Psychopharmacol; 1980; 21():67-80. PubMed ID: 6246760
    [No Abstract]   [Full Text] [Related]  

  • 6. Decamethonium both opens and blocks endplate channels.
    Adams PR; Sakmann B
    Proc Natl Acad Sci U S A; 1978 Jun; 75(6):2994-8. PubMed ID: 307251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug blockade of open end-plate channels.
    Adams PR
    J Physiol; 1976 Sep; 260(3):531-52. PubMed ID: 10432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quinacrine (mepacrine) action at frog end-plate.
    Adams PR; Feltz A
    J Physiol; 1980 Sep; 306():261-81. PubMed ID: 6257896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of pH and curare on the time course of end-plate currents at the neuromuscular junction of the frog.
    Mallart A; Molgó J
    J Physiol; 1978 Mar; 276():343-52. PubMed ID: 25959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-competitive effects of disopyramide at the neuromuscular junction: evidence for endplate ion channel block.
    Jones SV; Marshall IG
    Br J Anaesth; 1987 Jun; 59(6):776-83. PubMed ID: 2440467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction between hexamethonium and tubocurarine on the rat neuromuscular junction.
    Rang HP; Rylett RJ
    Br J Pharmacol; 1984 Mar; 81(3):519-31. PubMed ID: 6141831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of tubocurarine competition on the kinetics of agonist action on the nicotinic receptor.
    Colquhoun D; Sheridan RE
    Br J Pharmacol; 1982 Jan; 75(1):77-86. PubMed ID: 6978750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An attempt to distinguish between the actions of neuromuscular blocking drugs on the acetylcholine receptor and on its associated ionic channel.
    Lambert JJ; Volle RL; Henderson EG
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):5003-7. PubMed ID: 6254051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of (+)-tubocurarine on neuromuscular transmission during repetitive stimulation in the rat, mouse, and frog.
    Magleby KL; Pallotta BS; Terrar DA
    J Physiol; 1981 Mar; 312():97-113. PubMed ID: 6267269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Variation of the time constant (tau) of the decay of end-plate current during focalized transmitter release].
    Bournaud R; Mambrini J
    C R Acad Hebd Seances Acad Sci D; 1977 Jun; 284(24):2511-4. PubMed ID: 409528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of current-voltage relations for full and partial agonists.
    Adams PR; Sakmann B
    J Physiol; 1978 Oct; 283():621-44. PubMed ID: 309943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of action of acetylcholine antagonists on rat parasympathetic ganglion cells.
    Ascher P; Large WA; Rang HP
    J Physiol; 1979 Oct; 295():139-70. PubMed ID: 42780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of (+)-tubocurarine blockade at the neuromuscular junction.
    Le Dain AC; Madsen BW; Edeson RO
    Br J Pharmacol; 1991 Jun; 103(2):1607-13. PubMed ID: 1884116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Voltage dependence of agonist effectiveness at the frog neuromuscular junction: resolution of a paradox.
    Dionne VE; Stevens CF
    J Physiol; 1975 Oct; 251(2):245-70. PubMed ID: 1081139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-and post-junctional effects of tubocurarine and other nicotinic antagonists during repetitive stimulation in the rat.
    Gibb AJ; Marshall IG
    J Physiol; 1984 Jun; 351():275-97. PubMed ID: 6747867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.